Clinical Trial Update: Novel Use of Restasis and PROSE Devices [Phase 3]

View source ↗

Summary

A Phase 3 trial investigating a novel use of Restasis and PROSE devices for ocular surface disease was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Surface Disease

Drugs mentioned

• Restasis (Cyclosporine A)

Snippet

Sponsor: Boston Sight | Conditions: Ocular Surface Disease | Phase 3 | Status: WITHDRAWN